Press release
Surging Cardiovascular Diseases Propel Growth In The Inotropic Agent Market: Strengthening the Growth Trajectory of the Inotropic Agents Market
Inotropic Agents Market
What Is the Expected CAGR for the Inotropic Agents Market Through 2025?
The market size for inotropic agents has expanded significantly in the previous years. The market is expected to increase from $2.56 billion in 2024 to $2.84 billion in 2025, indicating a compound annual growth rate (CAGR) of 11.1%. The historic growth is linked to factors such as educational and awareness initiatives, broadening of cardiac treatment possibilities, creation of safer agents, enhanced patient results, and regulatory approvals.
What's the Projected Size of the Global Inotropic Agents Market by 2029?
The market size for inotropic agents is projected to quickly expand over the coming years, escalating to "$4.52 billion by 2029, reflecting a compound annual growth rate (CAGR) of 12.3%. This anticipated growth during the forecasted period is linked to the increasing prevalence of cardiovascular diseases, advancements in drug delivery systems, the implementation of personalized medicine, expanded research funding, and a spiked demand for combination therapies. Throughout the forecast period, the industry will also see considerable trends such as patient education and awareness, specific targeting of cardiomyopathies, emphasis on managing heart failure, combination therapies, and enhanced safety profiles.
View the full report here:
https://www.thebusinessresearchcompany.com/report/inotropic-agents-global-market-report
Top Growth Drivers in the Inotropic Agents Industry: What's Accelerating the Market?
The escalation in the occurrence of cardiovascular diseases is primarily fueling the growth of the inotropic agent market. Cardiovascular diseases, also known as CVDs, encompass conditions affecting the vascular system and the functionality of the heart. These diseases are commonly treated with inotropic agents, which enhance the heart's contractility and functionality, address cardiac shock, and decrease the heart rate by enabling the heart to contract more forcefully and thus, increase blood flow. This, in turn, acts as a catalyst for the growth of the inotropic agent market. For instance, in October 2022, the Centers for Disease Control and Prevention, a governmental agency of the United States, shared reports stating that heart diseases were the primary cause of death in the nation. Approximately 697,000 people succumbed to heart disease in 2020, accounting for nearly one-fifth of all deaths. Additionally, around 20.1 million adults were diagnosed with coronary artery disease and approximately 805,000 people in the United States experienced a heart attack annually. Moreover, the American College of Cardiology, a nonprofit medical association based in the United States, predicted in August 2022 that the risk of stroke would rise by 33.8 percent to 15 million between 2025 and 2060. Thus, the increasing prevalence of cardiovascular ailments is accelerating the growth of the inotropic agent market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10711&type=smp
What Trends Will Shape the Inotropic Agents Market Through 2029 and Beyond?
Drug approval plays a significant role in the inotropic agents market. In April 2022, US-based Bristol-Myers Squibb received FDA approval for Camzyos (mavacamten), a selective cardiac myosin inhibitor. It treats class II-III obstructive hypertrophic cardiomyopathy by reducing excessive heart muscle contractions and improving patient symptoms.
What Are the Main Segments in the Inotropic Agents Market?
The inotropic agents market covered in this report is segmented -
1) By Type: Positive Inotropic Drugs, Negative Inotropic Drugs, Other Types
2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
3) By Indication: Heart Attack, Heart Failure, Angina, Arrhythmia, Other Indications
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
5) By End User: Hospital, Homecare, Specialty Centers, Other End Users
Subsegments:
1) By Positive Inotropic Drugs: Cardiac Glycosides, Catecholamines, Phosphodiesterase Inhibitors
2) By Negative Inotropic Drugs: Beta Blockers, Calcium Channel Blockers
3) By Other Types: Mixed Inotropic Drugs, Experimental Inotropic Agents
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10711&type=smp
Which Top Companies are Driving Growth in the Inotropic Agents Market?
Major companies operating in the inotropic agents market include Pfizer Inc., GSK plc, Novartis AG, Mylan N.V., Boehringer Ingelheim International GmbH, AstraZeneca plc, Johnson & Johnson, Bayer AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Cipla Ltd., Eli Lilly And Company, Sanofi S.A., Baxter International Inc., Hikma Pharmaceuticals plc, Sun Pharmaceuticals Industries Ltd., Cadila Pharmaceuticals Ltd., AbbVie Inc., Allergan plc, Amgen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Fresenius Kabi AG, Genentech Inc., GlaxoSmithKline plc, Intas Pharmaceuticals Ltd., Lupin Limited, Regeneron Pharmaceuticals Inc., Roche Holding AG, BioNTech SE
Which Regions Will Dominate the Inotropic Agents Market Through 2029?
North America was the largest region in the inotropic agents market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global inotropic agents market report during the forecast period. The regions covered in the inotropic agents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10711
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Surging Cardiovascular Diseases Propel Growth In The Inotropic Agent Market: Strengthening the Growth Trajectory of the Inotropic Agents Market here
News-ID: 4106291 • Views: …
More Releases from The Business Research Company
Global Factors Influencing the Rapid Evolution of the Robotic Flight Simulator S …
The robotic flight simulator surgery market is on the verge of significant expansion as advanced technologies continue to reshape surgical training and planning. Driven by increasing adoption of virtual reality and innovative simulation tools, this sector is set to experience considerable growth over the coming years. The following analysis explores the market's valuation, key contributors, evolving trends, and the segmentation landscape.
Projected Market Size and Growth Trajectory of the Robotic Flight…
Leading Companies Consolidating Their Presence in the Responsible Artificial Int …
As artificial intelligence (AI) technologies continue to evolve and integrate deeply into business operations, the need for transparent and accountable AI practices has never been more critical. The responsible artificial intelligence (AI) reporting packs market is emerging as a vital sector dedicated to ensuring that AI systems are monitored, governed, and reported with rigor. Let's explore the expected growth, key players, industry trends, and market segments shaping this important field.
Projected…
Future Perspective: Key Trends Shaping the Regenerative Grid Simulator Market Up …
The regenerative grid simulator market is on track for significant expansion as technological advancements and increasing energy demands drive innovation. With rising focus on smart grids and electric vehicle infrastructure, this market is poised to transform energy testing and validation processes in the coming years. Here's an in-depth look at the market's size, key players, emerging trends, and major segments shaping its future.
Forecast and Market Size Growth in the Regenerative…
Analysis of Key Market Segments Driving the Quic-Enabled Content Delivery Networ …
The quic-enabled content delivery network edge industry is on track for remarkable expansion over the coming years. Driven by evolving digital needs and technological advancements, this market is set to transform how content is delivered and experienced globally. Let's explore its market size, key players, prevailing trends, and segment-specific forecasts to understand the future trajectory of this dynamic sector.
Projected Market Growth and Size of the Quic-Enable Content Delivery Network Edge…
More Releases for Inotropic
Top Trends Transforming the Inotropic Agents Market Landscape in 2025: Bristol-M …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Inotropic Agents Industry Market Size Be by 2025?
Over the previous years, the inotropic agents market has seen quick expansion. Predictions for growth anticipate it to rise from $2.56 billion in 2024 to $2.82 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.5%.…
Inotropic Agent Market Key Players, Share and Forecast Outlook
On May 13 , 2025, Exactitude Consultancy., Ltd. released a research report titled "Inotropic Agent Market". This report covers the global Inotropic Agent market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends. Along…
Inotropic Agent Market Key Players, Share and Forecast Outlook
On May 12 , 2025, Exactitude Consultancy., Ltd. released a research report titled "Inotropic Agent Market". This report covers the global Inotropic Agent market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends. Along…
Surging Cardiovascular Diseases Propel Growth In The Inotropic Agent Market Driv …
What market dynamics are playing a key role in accelerating the growth of the inotropic agents market?
The increase in occurrences of cardiovascular diseases is fueling the growth of the inotropic agent market. Cardiovascular diseases, which pertain to disorders of the heart and vascular system, are often treated with inotropic agents. These substances enhance the heart's contractility, help manage cardiac shock, and slow down the heart rate by assisting the heart…
Inotropic Agents Market: Exploring Size, Growth Rate, Drivers, and Trends
Expanding Scope and Implications of Inotropic Agents in Cardiac Health
What Is The Projected Market Size Of The Global Inotropic Agents Market And Its Growth Rate?
The inotropic agents market has seen a significant growth, driven by the medical advancements and the rising awareness of cardiac health.
• Market size in 2024: $2.56 billion
• Market size in 2025: $2.84 billion (11.1% CAGR)
• Expected Market size in 2029: $4.52 billion (12.3% CAGR)
The key factors…
Insights into Inotropic Agents Market: Global Trends and Analysis
The inotropic agents market size has grown rapidly in recent years. It will grow from $2.32 billion in 2023 to $2.59 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to education and awareness initiatives, expansion of cardiac treatment options, development of safer agents, improved patient outcomes, regulatory approvals.
The inotropic agents market size is expected to…
